Amphastar Pharmaceuticals, Inc.
AMPH
$19.19
-$0.36-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.80% | -44.09% | 22.72% | -33.40% | -6.10% |
| Total Depreciation and Amortization | 1.39% | -2.90% | 6.79% | 3.70% | 1.60% |
| Total Amortization of Deferred Charges | -2.15% | 5.11% | 10.50% | 5.25% | -2.69% |
| Total Other Non-Cash Items | 421.19% | 9.61% | -43.00% | 166.95% | -234.71% |
| Change in Net Operating Assets | -456.16% | 164.76% | -10.84% | -94.58% | -17.24% |
| Cash from Operations | -37.50% | 47.74% | 1.47% | 20.86% | -51.60% |
| Capital Expenditure | -54.67% | 49.38% | 1.23% | 13.81% | 10.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -266.46% | -243.57% | -53.06% | 191.02% | -11.90% |
| Cash from Investing | -208.73% | -3,039.04% | -105.96% | 129.38% | -3.16% |
| Total Debt Issued | 58.72% | -95.83% | 151.46% | -66.27% | -48.80% |
| Total Debt Repaid | -136.36% | -18.92% | 2.63% | 66.96% | -180.49% |
| Issuance of Common Stock | 422.96% | -23.28% | -- | -- | -- |
| Repurchase of Common Stock | -323.01% | 85.96% | -120.18% | 59.38% | -21.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 98.42% | 40.05% | -2,018.18% | 103.75% |
| Cash from Financing | -322.66% | 85.61% | -108.25% | 57.14% | -48.33% |
| Foreign Exchange rate Adjustments | 78.05% | -128.87% | 20.34% | 1,172.73% | 82.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -261.28% | 482.35% | -84.26% | 176.96% | -1,722.23% |